Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Gestarelle G is a comprehensive multi-nutrient dietary supplement specifically formulated to support women's nutritional needs from the pre-conception period through pregnancy and breastfeeding. Developed by Laboratoire IPRAD and marketed in various regions by GyneBio Pharma, the supplement provides a balanced complex of essential vitamins, minerals, and trace elements. Key components include folic acid (Vitamin B9), which is critical for preventing neural tube defects; iodine, essential for maternal thyroid function and fetal neurological development; and iron, which supports the increased demand for hemoglobin synthesis. Furthermore, Gestarelle G contains omega-3 fatty acids, specifically docosahexaenoic acid (DHA), which plays a vital role in the structural development of the fetal brain and retina. The product is designed to optimize maternal health and ensure the healthy growth and development of the fetus.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Gestarelle G.